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At 3 days, histology revealed acute inflammatory cells (neutrophils and monocytes) that 
transitioned to chronic inflammatory cells (lymphocytes) by 30 days. Vessel injury score 
was greater at 30. 90 and 160 days vs. 3 days while the inflammation score was 
increased at 160 days as compared with 30 and 90 days (p < 0.05). Neointimal formation 
peaked at 90 to1 80 days. Western blot analysis of markers of cell cycle activity demon- 
strated significant elevation of PCNA and CDC2 at 90 days. Conclusion: This data sug- 
gests that the processes of arterial repair persist beyond 30-days after stent placement in 
the porcine coronary model. Thus, longer time periods of study (90 days) may be neces- 
sary to observe maturation of arterial repair. Chronic inflammation and activation of the 
cell cycle represent potential therapeutic targets for the prevention of restenosis. 
1031-176 Estrogen Is Vasoprotective in Osteopontin Deficient 
Mice 
Todd Tolbefi, Philippe Bouchard, David Denhardt. Suzanne Oparil, The Umversity of 
Alabama at Birmingham, Birmingham, AL 
Background: Estrogen is vasoprotective in animal models of vascular injury, yet the 
mechanisms involved are incompletely understood. Many lines of evidence indicate that 
osteopontin (OPN) plays a role in neointima formation following arterial injury and that 
17P-estradiol (6) modulates OPN expression. This study tested the hypothesis that 6 
reduces neointima formation following vascular injury via a mechanism that is dependent 
on modulation of OPN expression. 
Methods: Male and female wild type (OPN+/+) mice and mice with homozygous deletion 
of the osteopontin gene (OPN-/-) were studied intact (INT) or following ovariectomy 
(OVX) and implantation of b or vehicle (V) pellets. Mice were randomized to 6 groups 
based on gender, OPN status, OVX, and treatment with E, or V (n=7-6 per group). Mica 
were sacrificed 26 days after carotid artery ligation, and occluded vessels were evalu- 
ated for neointlma formation using morphometric analysis. Results are expressed as 
means * SEM. 
Results: Occluded vessels from OPN-I- mice demonstrated reduced neointima forma- 
tion compared to those from OPN+/+ mice of similar sex and treatment group. There was 
a marked sexual dimorphism in neointima formation in both the OPN+/+ mice and the 
OPN-/- mice. OPN+/+ INT females had a 70% reduction in neointima formation com- 
pared to OPN+/+ males (1.21+0.20x1@ & vs 4.14iO.42 x104 pmz; p<O.O5), and OPN- 
/- INT females had a 72% reduction in neointima formation compared to OPN-I- males 
(0.47+0.05x104 pm’ vs 1.67iO.41 xl@ Km? ~~0.05). The sexually dimorphic response 
was attenuated by OVX and restored by E, replacement in both the OPN+/+ and OPN-/- 
mice. Female OPN+/+ OVX+E, mice had an 62% reduction in neointima formation com- 
pared to female OPN+/+ OVX+V mice (0.48~0.03~1~ pm* vs 2.63*0.37 x104 PIT?; 
p<O.O5), and female OPN-I- OVX+E, mice had a 59% reduction in neointima formation 
compared to female OPN-/- OVX+V mice (0.50+0.09xlod pm2 vs 1.22tO.22 x10” pm$ 
P-zO.05). 
Conclusions: These results demonstrate that the vasoprotective effects of E, following 
ligation vascular injuly are, at least in part, independent of OPN expression. 
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a Murine Model of Obesity and Diabetes 
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NY 
Diabetes is an independent risk factor for restenosis following coronary angioplastylstent 
implantation. We hypothesized that the metabolic abnormalities present in diabetes 
would promote neointimal formation in response to arterial injury through alterations in 
vascular smooth muscle cell (VSMC) migration and proliferation. Bilateral femoral artery 
endovascular injury was performed in dbldb mice (Lepr db’dy, which have a mutation in 
the leptin receptor gene, resulting in defective kptin signaling.Compared to lean wild 
type littermates control (Lepr +I+ ),db/db mice are obese and develop overt diabetes by 
four weeks of age. At baseline, there were no significant differences in femoral artery 
dimensions in the two groups of mice. Bilateral femoral artery injury was performed in 
Lepr+‘+ and Lep@b’db mice using a 0.30mm angioplasty guide wire. mice were then sac- 
rificed at 2 weeks and 4 weeks after artenal injury for measurement of neointima. Supris- 
ingly, at both timepoints neointimal area was dramatically reduced by > 90% in Leprdbidb 
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mice compared to age and gender matched Lepr++ mice.At 4 weeks after injury lntimal 
area (0.0006 * 0.0003 vs. 0.012 * 0.0022 mm2, n=&p= 0.0006) and intimal~medial ratio 
(.056 * 0.02 vs. 0.63 f 0.16 mm2,n=6,p =0.0007) were decreased by 95% and 93%, 
respectively in LepflMdb mice when compared to Lepr+‘+ mice. To gain insight into the 
mechanism(s) responsible for the attenuated neointimal response in the LepPb’db mice, 
we sacrificed mice from each group at 4 hours after injury. At this early timepoint the 
extent of medial smooth muscle cell death was paradoxically diminished in Le~fl~‘~~ 
compared to Lepf”+ mice. In addition the area of the vessel wall occupied by TUNEL+ 
VSMC was also significantly decreased in LepPb’db rmce (0.5 * 1.5, vs. 12 * 12 %, n&, 
Mann-Whitney p<O.O05), implicating alterations in VSMC apoptosis. There were no qual- 
itative differences in endothelial denudation and platelet adherence, to injured arteries 
from Lepr +” and Lepr “ldb mice. These studies suggest a potential novel role for leptin 
in the regulation of smooth muscle proliferationlapoptosis in response to endovascular 
arterial injury. 
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Background: AM regulates cellular processes including proliferation, migration and sur- 
vival, which are required for neointimal hyperplasia. But, there is no in viva study to show 
the role of Akt in the restenosis after angioplasty We examined the role of AM in vascular 
response to injuty by modulating Akt activity through gene therapy. 
Methods: We used two adenoviral constructs to modulate AM activity : (1) DN(dominant- 
negative)-AM construct has two phosphorylation site serine473, threonine306 mutated to 
alanine, which results in the unphospholylatable and defective Akt. (2) myr-Akt construct 
is myristoylated at its N-terminal end, which results in the constitutively active AM. Adult 
male Sprague-Dawley rats which underwent balloon denudation injury on carotid artery 
were divided into three groups, Adeno-Green Fluorescent Protein(GFP) (n=lO), Adeno- 
DN-AM (n=lO), Adeno-myr-Akt (n=l@. After balloon injury, 3x10s pfu of adenovitus in 
2OuL was delivered to the injury segment and incubated for 20min with vascular clamp. 
Results: At 3 days after gene transfer, overexpression of myr-AM or DN-Akt was con- 
firmed by Western blot analysis for Akt. Compared to Adeno-GFP. adeno-DN-Akt signifi- 
cantly inhibited cell proliferation as shown by immunohistochemistry for proliferating cell 
nuclear antigen(PCNA) and enhanced apoptosis in TUNEL staining, which led to signifi- 
cant reduction of intimal hypetplasia (IntimaIMedia ratio GFP:DN-Akt 0.61iO.19: 
0.39kO.22. p&.05) at 14 days after gene transfer. In contrast, adeno-myr-Akt showed a 
trend for aggravation of neointimal hyperplasia, and increase of cell infiltration and prolif- 
eration compared to Adeno-GFP. Interesting finding, however, is that adeno-myr-Akt 
increased medial hypeltrophy, which is consistent finding with other studies that showed 
Akt induced skeletal or cardiac muscle hypertrophy.(myr-Akt:DN 0.17a0.02: 0.14+0.04 
md, pcO.05) 
Conclusion: Inhibition of AM reduced intimal hyperplasia, whereas activation of Akt 
induced medial hypertrophy and aggravation of neointima. These findings suggest that 
Akt, a regulator of cell proliferation and hypertrophy, is a key molecule to modulate the 
vascular response to injuly 
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Muscle Cell Proliferation Without Compromising Vessel 
Wall Mechanical Strength 
Ron Waksman, Ian Leitch, Ray Hunter, John Roessler, Tom Bulinski, Hamid Yazdi, Jana 
Fourdnajiev, Edward F. Cheneau, Allister Wilson, Kevin Floras. Jane Yamada, Erik 
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Background: Intravascular PhotoPointrM Photodynamic therapy (PDT) using light acti- 
vation of the novel photosensitizer MV0633 is a potential treatment for restenotic and 
atherosclerotic lesions. The aims of this study were to investigate the effects of Photo- 
Point PDT on (a) the treated vessel wall integrity, mechanical strength and SMC density, 
and (b) the inhibition of neo-intimal proliferation aHer balloon angioplasty. 
Methods: In one study group, rats received MV0633 (1.4 mg/kg, iv) and 4 hrs later intra- 
vascular light activation (SOJ/cfi in carotid arteries. The alteries were assessed at 5 
days for (i) changes in cellular density, (ii) alterations of collagen cross-links as indirectly 
measured by shrink temperature (Ts), and (iii) the intraluminal hydrostatic burst pressure. 
In a second study group, swine undelwent PTCA and intracoronary PhotoPoint (MV0633 
@ 3 mg/kg iv: light @ 125 J/w?). Treated vessels were analyzed at 14 days by histo- 
morphometry. 
Results: PhotoPoint treated arteries were patent and showed a reduction in SMC den- 
sity (> 90 %) without thrombosis or inflammation. Mean Ts was increased in PhotoPoint 
treated arteries (82 + 5°C) vs. controls (73 + 4°C). Hydrostatic burst pressure of treated 
and control arteries were similar (PDT: 77 t 2.9 psi vs. control: 76 * 6.7 psi). At 14 days 
after PTCA, the ratio of intimal area / fracture length was reduced in the PhotoPoint 
group compared to controls (0.34 * 0.05 mn?vs. 0.62 * 0.07 mm’, p c 0.01). 
Conclusions: These data suggest that intravascular PhotoPoint PDT with the new drug 
MV0633 can cause pronounced inhibition of SMC proliferation and an increase in col- 
lagen cross-linking without risk of thrombosis, inflammation or weakening of the vessel 
Wall. 
